FLD
Fold Holdings, Inc. Class A Common StockNASDAQFINANCIAL SERVICESCAPITAL MARKETS
Key Statistics
Market Cap
$56.37M
P/E Ratio
—
EPS
$-0.32
Beta
0.38
52W High
$5.54
52W Low
$1.00
50-Day MA
$1.33
200-Day MA
$2.53
Dividend Yield
—
Profit Margin
-164.60%
Forward P/E
—
PEG Ratio
—
About Fold Holdings, Inc. Class A Common Stock
Fold Holdings, Inc. (FLD) is an innovative biotechnology company dedicated to advancing therapies for severe genetic and rare diseases through its pioneering research initiatives. With a robust product pipeline fortified by proprietary technologies and strategic collaborations, Fold is well-positioned to capitalize on emerging market opportunities. Its commitment to scientific excellence and patient-focused solutions underscores its potential for sustainable growth and value creation, making FLD an attractive investment prospect in the rapidly evolving healthcare sector.
Fundamentals
| Revenue (TTM) | $30.30M |
| Gross Profit (TTM) | $-13.26M |
| EBITDA | $-26.89M |
| Operating Margin | -167.00% |
| Return on Equity | -92.20% |
| Return on Assets | -15.00% |
| Revenue/Share (TTM) | $0.63 |
| Book Value | $0.72 |
| Price-to-Book | 1.55 |
| Price-to-Sales (TTM) | 1.86 |
| EV/Revenue | 2.541 |
| EV/EBITDA | 4.04 |
| Quarterly Earnings Growth (YoY) | 1622.00% |
| Quarterly Revenue Growth (YoY) | -21.10% |
| Shares Outstanding | $50.78M |
| Float | $5.26M |
| % Insiders | 71.33% |
| % Institutions | 15.24% |
Historical Volatility
HV 10-Day
121.79%
HV 20-Day
100.49%
HV 30-Day
129.02%
HV 60-Day
124.47%
HV Rank
86.5%
Volatility is currently contracting
Analyst Ratings
Consensus ($3.41 target)
3
BuyMore FINANCIAL SERVICES Stocks
Data last updated: 5/25/2026